与代谢功能障碍相关的脂肪性肝病和供体肝损伤的发病因子
Chuheng Gou1, Wenjie Zhang1, Hao Xu1
1Department of Hepatobiliary Surgery, XiJing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi, China.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 影响肝脏捐赠. 了解MASLD的发病机制和移植损伤机制可以改善供体肝脏的利用率和移植结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植免疫学 移植免疫学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 影响全球超过25%的成年人.
- MASLD对健康造成重大负担,并限制了肝脏捐赠者的可用性.
- 缺乏对MASLD病原和移植损伤的系统评估.
研究的目的:
- 系统地审查MASLD的病原性.
- 为了阐明MASLD供体肝损伤的机制.
- 提出提高MASLD供体肝脏利用率和移植保存的策略.
主要方法:
- 对现有文献进行系统审查.
- 在MASLD中分析分子和病理途径.
- 在MASLD供体肝脏中损伤机制的评估.
主要成果:
- MASLD的发病包括遗传学,代谢/内分泌因素,肠道微生物群和炎症.
- 脂质积累,内质网膜压力和纤维化是关键的驱动因素.
- 由于脂质沉积和炎症,MASLD肝脏容易发生缺血-再输血和冷缺血损伤.
结论:
- MASLD的发病因子是多因素的,导致肝纤维化和易受移植损伤.
- 尽量减少寒冷缺血时间和利用机器输液的策略至关重要.
- 移植后的MASLD治疗可能会提高移植的存活率.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
